dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Pöördumine

Sotsiaalministeerium · 24. märts 2021
Viit
1.4-2/1071-1
Registreeritud
24. märts 2021
Dokumendi liik
Sissetulev kiri
Adressaat
Ministry of Health of Latvija
Saabumis/saatmisviis
e-post
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-2 Rahvusvahelise koostöö korraldamisega seotud kirjavahetus (Arhiiviväärtuslik)
Toimik
1.4-2/2021
Vastutaja
Agnes Alajõe (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Euroopa Liidu ja väliskoostöö osakond)

Failid

  • 📎1494.pdf30 KB
  • 📎E-kiri.pdf115 KB
  • 📎Piel1_EGL MUT REQUIREMENTS.pdf93 KB

Sisu (failidest)

Saatja: <[email protected]> Saadetud: 24.03.2021 09:15 Adressaat: SM Info <[email protected]>; Ministry of Health of the Republic of Lithuania <[email protected]> Teema: 16.03.2021 Nr. 01-19.1/1494 "Par E.Gulbja laboratorijas testu jauno pieeju" LR Veselîbas ministrijaTâlr.: 67876000E-pasts: [email protected]âjaslapa: www.vm.gov.lv Ðî vçstule ir paredzçta tikai personai vai personu grupai, kurai tâ ir adresçta. Ðî e-pasta vçstule ir konfidenciâla, un var saturçt juridiski aizsargâtu informâciju. Ja neesat ðîs vçstules paredzçtais adresâts, paziòojam, ka vçstuli esat saòçmis kïûdas rezultâtâ, un pilnîga vai daïçja iepazîðanâs ar tâs saturu, vçstules izmantoðana vai tâlâka izplatîðana jebkâdâ veidâ ir stingri aizliegta. Ja esat saòçmis ðo vçstuli kïûdas dçï, lûdzu sazinieties ar sûtîtâju, nosûtot atbildes e- pasta vçstuli, pçc tam nekavçjoties vçstuli izdzçsiet (ieskaitot visus pielikumus). This e-mail is intended only for the person or group of people to whom it is addressed. This message is confidential and may contain legally privileged information. If you an erot the intended recine rt, you are hereby notified that you have received this message in error and that reading it, copying it, or in any way disclosing its content to any other person, is strictly unauthorized. If you have received this message in error, please inform the sender by replying to this e-mail and then immediately delete this e-mail (including any attachments). E.Gulbja Laboratorija Reģ. Nr. 42803008077 Brīvības gatve 366, Rīgā, LV-1006 Tālr. +371 67545052, fakss +371 67543867 E-pasts: [email protected] Swedbanka, kods HABALV22, konta Nr. LV14HABA0001408038877 Sample requirements for SARS-CoV-2 mutation testing by RT-PCR E. Gulbis Laboratory has developed a test which is currently being used routinely in Latvia for detection of N501Y mutation and further detection of the B.1.1.7 SARS-CoV-2 virus variants. The test detects E gene, RdRP gene and N501Y in a multiplex reaction, all N501Y “positive” samples are further tested if it is the B.1.1.7 variant. If N501Y is detected but B.1.1.7 is NOT confirmed it is recommended to perform a further viral genome sequencing. Turnaround time for the test is 24 hours. Sample requirements: • Nasopharyngeal and oropharyngeal swab in at least 300ul of transport medium (UTM or VTM) • Pozitive result where Ct value is less than or equal to 30 Any technical or additional details can be discussed via e-mail or by phone. Prepared by: Mikus Gavars +37129237678 [email protected]
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel